Profound Sexual Dysfunction Among Patients with Hidradenitis Suppurativa: A Cross-sectional Study Piotr K. KrajewskiAlexandra StrobelJacek C. Szepietowski Original Research Open access 13 June 2024
Successful Treatment of Severe Pemphigus Vulgaris with Reduced Side Effects Using a Novel IVIg Preparation Nadine WiedenmayerAnastasia S. VollmerAlexander H. Enk Case Report Open access 12 June 2024
Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review Kimberly N. WilliamsChrislene T. Y. OlukogaAntonella Tosti Review Open access 11 June 2024
Correction: Clinical Characteristics and Therapeutic Aspects of Blaschko Linear Psoriasis Ling ChenYufan ChengZhu Shen Correction Open access 05 June 2024 Pages: 1703 - 1703
Correction to: The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing Yuling ShiEdward LainAline Stennevin Correction Open access 03 June 2024 Pages: 1697 - 1701
Intradermal Injection in Balding Region Versus Intramuscular Injection in Surrounding Muscles: A Split-Scalp, Randomized Trial on BoNT for Androgenetic Alopecia Jiaqi LiShu ZhangXian Jiang Brief Report Open access 02 June 2024 Pages: 1671 - 1682
Health-Related Quality of Life Burden Among Adults with Vitiligo: Relationship to Disease Severity and Disease Location David RosmarinAhmed M. SolimanHeidi S. Camp Original Research Open access 02 June 2024 Pages: 1633 - 1647
Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies Michela StaraceStephano CedirianBianca M. Piraccini Review Open access 31 May 2024 Pages: 1457 - 1477
Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity April W. ArmstrongTarannum JaleelKurt de Vlam Original Research Open access 30 May 2024 Pages: 1615 - 1631
Beneficial Effects of Multi-Micronutrient Supplementation with Collagen Peptides on Global Wrinkles, Skin Elasticity and Appearance in Healthy Female Subjects Rachael GibsonLieselotte KrugSue Aspley Original Research Open access 30 May 2024 Pages: 1599 - 1614
Correction to: Burden of Topical Treatments in Psoriasis and Preferred Criteria of Choice: A Survey-Based Evaluation of Patients in Europe Anthony BewleyLauren HiribarneSicily Mburu Correction Open access 30 May 2024 Pages: 1515 - 1516
Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO) A. PinterA. CostanzoC. Schuster Correction Open access 30 May 2024 Pages: 1495 - 1496
A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis Paolo AmerioSilvia Mariel FerrucciMariateresa Rossi Review Open access 30 May 2024 Pages: 1443 - 1455
Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT Masatoshi AbeYukari OkuboRyosuke Hino Original Research Open access 27 May 2024 Pages: 1587 - 1597
Efficacy and Safety of Oxymatrine in the Treatment of Patients with Erythrodermic Psoriasis Huijuan ShiDongmei ChenFang Wang Brief Report Open access 26 May 2024 Pages: 1659 - 1670
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data Andreas PinterAhmed M. SolimanMark G. Lebwohl Original Research Open access 24 May 2024 Pages: 1575 - 1585
Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch José-Manuel CarrascosaAlessandra NarcisiAndreas Wollenberg Original Research Open access 22 May 2024 Pages: 1561 - 1573
Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review Miguel Mansilla-PoloDaniel Morgado-Carrasco Review Open access 19 May 2024 Pages: 1389 - 1442
Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients Funda ErduranEsra AdışenAkın Aktaş Original Research Open access 17 May 2024 Pages: 1547 - 1560
A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria Adam FriedmanShawn G. KwatraGil Yosipovitch Review Open access 17 May 2024 Pages: 1371 - 1387
Patient Burden of Nonsegmental Vitiligo: A US Real-World Survey of Dermatologists and Their Patients David RosmarinJennifer H. LoflandJinan Liu Original Research Open access 16 May 2024 Pages: 1531 - 1546
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis) Mario ValentiLuigi GargiuloAlessandra Narcisi Brief Report Open access 15 May 2024 Pages: 1649 - 1657
Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis Lin MaXiaohua TaoJianzhong Zhang Original Research Open access 15 May 2024 Pages: 1229 - 1243
Anti-aging Effects of Tirbanibulin 1% Ointment: A Real-Life Experience Federica Li PomiLucia PeterleFrancesco Borgia Case Series Open access 14 May 2024 Pages: 1683 - 1696
Enthesitis and Dactylitis Resolution with Risankizumab for Active Psoriatic Arthritis: Integrated Analysis of the Randomized KEEPsAKE 1 and 2 Trials Shawn G. KwatraSaakshi KhattriDennis McGonagle Original Research Open access 13 May 2024 Pages: 1517 - 1530
Effects of 15% Azelaic Acid Gel in the Management of Post-Inflammatory Erythema and Post-Inflammatory Hyperpigmentation in Acne Vulgaris Huidi ShuchengXinyu ZhouXian Jiang Original Research Open access 11 May 2024 Pages: 1293 - 1314
Unmet Needs and Treatment Preference of Systemic Treatments for Moderate-to-Severe Psoriasis from the Perspectives of Patients and Dermatologists in China Yehong KuangYuzhen LiSteven Feldman Original Research Open access 11 May 2024 Pages: 1245 - 1257
Comparison of the Efficacy of Clascoterone, Trifarotene, and Tazarotene for the Treatment of Acne: A Systematic Literature Review and Meta-Analysis Mahek ShergillMuhammad Usman AliMohannad Abu-Hilal Review Open access 11 May 2024 Pages: 1093 - 1102
OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting Sarah AlulisNicoletta BernardiniFareen Hassan Original Research Open access 10 May 2024 Pages: 1273 - 1291
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study Andreas PinterAhmed M. SolimanMark Lebwohl Original Research Open access 10 May 2024 Pages: 1259 - 1271
Cutaneous Superficial Basal Cell Carcinoma is a Basal Cell Carcinoma In Situ: Electron Microscopy of a Case Series of Basal Cell Carcinomas Harsimran KaurKaren L. de Mesy BentleyBruce R. Smoller Case Series Open access 09 May 2024 Pages: 1359 - 1366
Brodalumab: 5-Year US Pharmacovigilance Report Mark G. LebwohlJohn Y. KooAbby A. Jacobson Brief Report Open access 09 May 2024 Pages: 1349 - 1357
Comparative Study on the Duration and Efficacy of Various Botulinum Toxin Type A Injections for Reducing Masseteric Muscle Bite Force and Treating Facial Wrinkles Surachet SirisuthivoranuntSupisara WongdamaRungsima Wanitphakdeedecha Original Research Open access 09 May 2024 Pages: 1315 - 1325
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis Leon H. KircikLinda Stein GoldWilliam Philip Werschler Original Research Open access 09 May 2024 Pages: 1211 - 1227
High Intensity Focused Ultrasound (20 MHz) and Cryotherapy as Therapeutic Options for Granuloma Annulare and Other Inflammatory Skin Conditions Jacek CalikTomasz ZawadaTorsten Bove Original Research Open access 04 May 2024 Pages: 1189 - 1210
Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From the ESSENTIAL AD Multicountry Study Spyridon GkalpakiotisSusanna KannenbergIman Almasry Original Research Open access 04 May 2024 Pages: 1173 - 1187
Telemedicine in Nail Psoriasis: Validation of a New Tool to Monitor (In-Person, In-Picture, and In-Video) Nail Psoriasis Severity in Patients with Concurrent Onychophagia and Onychotillomania Alessia PacificoMatilde IorizzoGiovanni Damiani Original Research Open access 03 May 2024 Pages: 1161 - 1172
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis Eric L. SimpsonMarjolein de Bruin-WellerJonathan I. Silverberg Original Research Open access 03 May 2024 Pages: 1145 - 1160
Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review Elisa MolinelliHelena GioacchiniOriana Simonetti Review Open access 03 May 2024 Pages: 1079 - 1091
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2) Eric L. SimpsonVimal H. PrajapatiJonathan I. Silverberg Original Research Open access 02 May 2024 Pages: 1127 - 1144
Safety and Effectiveness of Percutaneous Ultrasound-Guided Galvanic Current in Tunnels of Patients with Hidradenitis Suppurativa: A Pilot Study Alberto Soto-MorenoCarlos Cuenca-BarralesAlejandro Molina-Leyva Original Research Open access 27 April 2024 Pages: 1115 - 1125
When Patient Diversity Informs Formulation: Reimagining Treatment for Seborrheic Dermatitis Meredith Tyree PolaskeyHeather Woolery-LlloydRaj Chovatiya Commentary Open access 27 April 2024 Pages: 1071 - 1077
Impact of Biologic Therapy on Key Cardiovascular Risk Parameters in a Psoriatic Cohort—a Retrospective Review Joseph JosephKelvin TruongAnnika Smith Brief Report Open access 25 April 2024 Pages: 1337 - 1348
Economic Burden of Itch-Related Sleep Loss in Moderate-to-Severe Atopic Dermatitis in the United Kingdom Evangeline J. PierceRussel T. BurgeYunni Yi Original Research Open access 23 April 2024 Pages: 1103 - 1114
Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO Elisabeth RiedlAndreas PinterChristopher Schuster Brief Report Open access 22 April 2024 Pages: 1327 - 1335
Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60 Alexander EgebergJason E. HawkesApril Armstrong Original Research Open access 22 April 2024 Pages: 1007 - 1018
The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016 Sissel Brandt Toft SørensenPrethibha GeorgeVera Ehrenstein Original Research Open access 16 April 2024 Pages: 993 - 1006
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis Tiago TorresAnne Sohrt PetersenJosé Manuel Carrascosa Original Research Open access 13 April 2024 Pages: 983 - 992
Novel Topical Treatments for Itch Rami H. MahmoudOmar MahmoudGil Yosipovitch Review Open access 13 April 2024 Pages: 829 - 840
Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study Michela StaraceFrancesca PampaloniZoe Apalla Original Research Open access 10 April 2024 Pages: 953 - 970